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The ligands that interact with the vast majority of
small-molecule binding transcription factors are
unknown, a significant gap in our understanding of
sensory perception by cells. TetR-family regulators
(TFRs) are found in most prokaryotes and are
involved in regulating virtually every aspect of
prokaryotic life however only a few TFRs have been
characterized. We report the application of phyloge-
nomics to the identification of cognate ligands for
TFRs. Using phylogenomics we identify a TFR, KijR,
that responds to the antibiotic kijanimicin. We go
on to show that KijR represses a gene, kijX, which
confers resistance to kijanimicin. Finally we show
that KijX inactivates kijanimicin by the hydrolytic
removal of sugar residues. This is a demonstration
of antibiotic resistance by deglycosylation.
INTRODUCTION
Identifying small-molecule signals and their receptors is essen-
tial for our understanding of cellular signaling and communica-
tion. One-component regulators contain both sensory (ligand
binding) and regulatory (DNA binding) functions within the
same polypeptide and are the dominant means of sensory
perception in prokaryotes (Ulrich et al., 2005). Small-molecule
receptors such as one-component regulators can be easily iden-
tified based on conserved sequencemotifs; however, identifying
their cognate ligands is a much greater challenge. TetR-family
regulators (TFRs) are involved in adaptive responses in bacteria
and are one of the largest and most important families of
one-component small-molecule receptors (Ramos et al., 2005).
The best-characterized model for the family, TetR, is the
repressor of tetA, which encodes a tetracycline efflux pump
(Hillen and Berens, 1994; Orth et al., 2000). An appealing feature
of this family is that the genes encoding TFRs tend to be adjacent
to the target genes they regulate, as is the case for tetR and tetA,
which are divergently transcribed. We have shown that in most
cases it is straightforward to identify at least one direct target
gene for a previously unstudied TFR simply by investigating
genomic context. Although the majority of characterized TFRs232 Chemistry & Biology 20, 232–240, February 21, 2013 ª2013 Elseregulate efflux pumps, we have also shown that in fact most
TFRs actually control the expression of genes encoding cyto-
plasmic proteins, most of which are putative enzymes, suggest-
ing that TFRs regulate a vast array of cellular functions beyond
mere export (Ahn et al., 2012).
TetR binds the antibiotic tetracycline, trapping the protein in
a conformation that is no longer able to bind DNA and allowing
expression of tetA. The small-molecule ligands that are bound
by TFRs are often directly related to the genes regulated. In
the case of TetR and TetA, the same molecule, tetracycline, is
the ligand for both, and this appears to be a common feature
for the family (Noguchi et al., 2000; Puska´s et al., 2000; Sandu
et al., 2003; Kloosterman et al., 2007; Zhang et al., 2007a; Ostash
et al., 2008; Shimada et al., 2008; Le et al., 2009; Feng and
Cronan, 2011; Jime´nez et al., 2011; Li et al., 2011; Sakamoto
et al., 2011; Sullivan et al., 2011). We suggest therefore that
identifying the small-molecule ligands for TFRs of unknown
function is an exceptionally attractive means of elucidating
the biochemical function of the target gene(s) they regulate, in
addition to the biological role of the TFR itself.
TFRs are found in most species of bacteria and archaea and
play key regulatory roles in virtually every aspect of prokaryotic
physiology from primary metabolic processes to virulence,
antibiotic production and resistance, and cell-cell signaling
(Ramos et al., 2005). However, the small-molecule ligands and
biological roles have been identified for only a small number of
these regulators. In most cases, the inducing ligands for one-
component systems have been identified through painstaking
genetic analysis and biochemical purification (Fuqua and Green-
berg, 2002; Solomon et al., 1996; Chen et al., 2002). To date,
there has been no effort to organize TFRs, or any other family
of one-component regulatory protein, in a manner that specifi-
cally facilitates the identification of cognate small-molecule
ligands.
Although amino acid sequence similarity between newly
identified TFRs and previously characterized TFRs can provide
some information, these similarities usually result in the identifi-
cation of orthologs in closely related species and fail to offer
insights across a broader phylogenetic context. Additionally,
a simple BLAST search with a TFR of unknown function is
generally a frustrating endeavor because the large number of
sequences from whole-genome sequencing efforts overwhelms
similarity results with uninformative hits of other uncharacterized
proteins. The use of phylogenomics offers a solution to thesevier Ltd All rights reserved
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BLAST) in predicting protein function (Eisen, 1998) and has
been used to make general functional predictions for transcrip-
tion factors (Ibarra et al., 2008).
Here, we use a phylogenomics approach, employing a
neighbor-joining algorithm to group TFRs based on the amino
acid similarity, and present a global relational tree for the analysis
of TFRs in prokaryotes that organizes TFR sequences into
a manageable database. Importantly, we have included all of
the known TFR ligands in the relational tree and find that the
result is an extraordinary number of readily testable hypotheses
regarding the cognate ligands for TFRs of unknown function.
Using this information, we have successfully predicted the
inducing ligand for a TFR of unknown function in Streptomyces
coelicolor. We show that SCO7719 (KijR) binds the antibiotic
kijanimicin and that binding results in the expression of
SCO7720 (KijX), which encodes an enzyme conferring kijanimi-
cin resistance through a previously unknown deglycosylation
mechanism.
RESULTS
Phylogenomics CanBeUsed to Predict Cognate Ligands
for Transcription Factors
Weexamined 4,243 TFRs encoded in the genomes of 211 bacte-
rial and archaeal genomes (Table S1 available online). We
included a number of model prokaryotes (e.g., Escherichia coli,
Bacillus subtilis, Caulobacter crescentus, Myxococcus xanthus,
and Streptomyces coelicolor) and additional species to maxi-
mize phylogenetic diversity, including representatives from all
30 bacterial phyla, as well as ecological diversity, including
pathogenic, commensal, and environmental isolates. Our anal-
ysis highlights species that encode a high proportion of TFRs
in their genomes as well as those that lack TFRs (Figure S1).
The Actinobacteria, along with soil-dwelling Proteobacteria
encode the highest proportion of TFRs. Among these are patho-
gens that include Mycobacterium abscessus, Mycobacterium
tuberculosis, Nocardia farcinica, and opportunistic patho-
gens, including species of Acinetobacter, Burkholderia, and
Pseudomonas.
In addition to TFRs mined from genomic data, we included
226 TFRs of known or predicted biological function in our anal-
ysis (Table S2). Sixty-five different small-molecule ligands have
been experimentally identified for 56 of the known TFRs (some
TFRs bind more than one ligand, and some ligands are bound
by multiple TFRs). Of the 226 known TFRs, 110 are encoded
in the biosynthetic gene clusters for antibiotics and other
secondary metabolites. Evidence in the literature suggests that
many TFRs associated with biosynthetic gene clusters interact
with products of the cognate biochemical pathways (Tahlan
et al., 2007; Ostash et al., 2008; Le et al., 2009), and we use
this to suggest candidate ligands for additional TFRs.
To integrate this information into a global framework, we have
used phylogenetic methods to construct a neighbor-joining
tree that includes all 4243 TFR sequences (Figure S2) and have
incorporated all of the known and predicted TFR ligands in this
tree. Interrogation of our framework with an additional 219
TFRs from two other species (Burkholderia xenovorans LB400
and Streptomyces violaceusniger Tu 4113) indicates that ourChemistry & Biology 20, 232analysis captures most of the diversity of TFRs in the current
databases.
Phylogenetic methodologies have been used to examine and
organize different families of transcription factors and aid in
general functional preductions. They have been used to identify
subfamilies of NusG proteins (Belogurov et al., 2009), to identify
a subfamily ofMarR homologs that bind urate (Perera andGrove,
2011), and as a tool to predict the general regulatory roles of
AraC-family regulators (Ibarra et al., 2008). We have expanded
on these types of analyses for TFRs and used phylogenomics
to predict ligands for TFRs of unknown function. TFRs known
to bind similar ligands grouped together in our analysis and
can provide a critical basis for the characterization of TFRs of
unknown function. For example, TetR is found in the same
cluster as SCO0253 from S. coelicolor, which also binds tetracy-
cline (Hillen and Berens, 1994; Rodrı´guez-Garcı´a et al., 2005).
FabR and DesT, which both bind fatty acyl-CoAs and are
involved in regulating fatty acid saturation (Zhang et al., 2007b;
Feng and Cronan, 2011), are in the same group with many
TFRs of unknown function from both Gram-negative and
Gram-positive bacteria. Based on their clustering, we predict
that these unknown TFRs also play a role in fatty acid metabo-
lism. A further example of the reliability of our analysis is
that all 42 of the TFRs known to bind g-butyrolactone (GBL)
and related signal molecules (Okamoto et al., 1995; Onaka
et al., 1995; Takano et al., 2005; Kitani et al., 2011) are found in
a single cluster. These examples also serve to highlight some
of the diverse processes for which our framework has predictive
value, antibiotic resistance, primary metabolism, and cell-cell
signaling.
Many TFRs of unknown function grouped with TFRs encoded
in the biosynthetic gene clusters for antibiotics and other
secondary metabolites. These TFRs are known to regulate
secondary metabolite biosynthesis through GBL signaling
(Takano, 2006) or to regulate export and resistance to the
metabolites produced by these clusters (Tahlan et al., 2007;
Ostash et al., 2008; Le et al., 2009). Our framework allows these
TFRs to be easily distinguished. Where known, the expression
of export and self-resistance mechanisms is triggered through
the binding of biosynthetic products by the TFRs (Tahlan et al.,
2007; Ostash et al., 2008; Le et al., 2009; Xu et al., 2012) and
has provided numerous predictions concerning possible ligands
for individual TFRs and their neighbors in the relational tree.
Identification of a Group of TFRs that Interact
with the Antibiotic Kijanimicin
One TFR subfamily that we identified in the tree includes KijA8
from Actinomadura kijaniata and the TFR of unknown function
SCO7719 from S. coelicolor (Figure 1). KijA8 is encoded within
the biosynthetic cluster for the poorly understood antibiotic
kijanimicin (Zhang et al., 2007a). Kijanimicin belongs to a family
of antibiotics containing a spirotetronate moiety that shows
a diverse array of biological effects (Waitz et al., 1981). Kijanimi-
cin exhibits antibiotic activity against Gram-positive bacteria
as well as antitumor activity (Bradner et al., 1983), but its precise
mechanism of action is unknown. Structurally related molecules,
including tetrocarcin A and versipelostatin, also possess anti-
tumor activities that are of interest in the development of new
therapeutics (Morimoto et al., 1982; Park et al., 2004).–240, February 21, 2013 ª2013 Elsevier Ltd All rights reserved 233
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Figure 1. A Relational Framework Reveals Similarities between TFRs Encoded in Antibiotic Biosynthesis Clusters and TFRs of Unknown
Function
(A) Segment of the relational tree containing SCO7719 and KijA8. KijC5 and TcaR2 from the kijanimicin and tetrocarcin A biosynthetic clusters, respectively, are
also contained in this group. Kijanimicin and tetrocarcin A are structurally related molecules differing in glycosyl substitutions and modifications to the cyclo-
hexane ring (Tomita et al., 1980;Waitz et al., 1981). TFRs responding to kijanimicin and relatedmolecules are colored in green, whereas those found insensitive to
kijanimicin are colored in red. The full relational tree can be found in Figure S2. See also Figure S1 and Tables S1 and S2.
(B) Alignment of SCO7719 and KijA8. SCO7719 shares 41% identity (69% similarity) with KijA8 from the kijanimicin biosynthesis cluster inA. kijaniata (Zhang et al.,
2007a). This similarity is not limited to the DNA-binding domain (78% similarity) but extends through the ligand-binding domain (66% similarity).
(C) Organization of the SCO7719-SCO7720 divergon. The palindromic sequences predicted to be recognized by SCO7719 are highlighted with arrows. The DNA
fragment used in Figure 2B is boxed. An alternative, in frame ATG start site for SCO7720, is shown at the end of the sequence. A comparison with SCO7720
homologs from other Streptomycetes indicates that this alternative start site is more likely to be the relevant start site.
See also Tables S3 and S4.
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encodes a single putative kijanimicin export pump, KijA5,
a member of the Major Facilitator Superfamily (Zhang et al.,
2007a). We predicted that KijA8 binds and represses transcrip-
tion from the kijA5 promoter and that this repression is relieved
by kijanimicin. To confirm this, we created a luxCDABE reporter
in which the expression of kijA8 and the lux genes was under the
control of the kijA5 promoter. Light production was observed
only in the presence of kijanimicin (Figure 2A), indicating that
KijA8 represses the kijA5 promoter and controls expression of
the efflux pump encoded by kijA5. KijA5 expression, and hence
kijanimicin export and resistance in the producer A. kijaniata, is
regulated by KijA8 and induced by kijanimicin.
Based on the clustering of SCO7719 and KijA8 in our relational
tree, we investigated kijanimicin as an inducing ligand for
SCO7719 and several other TFRs in the same subgroup.
SCO7719 and SCO7720 are arranged in a manner analogous
to TetR and TetA (Bertrand et al., 1983); unlike kijA5, SCO7720
encodes a protein of unknown function. We therefore predicted
that SCO7719 is a regulator of SCO7720 expression. The
SCO7719-SCO7720 divergon is flanked by genes encoding
two proteins of unknown function, SCO7718 and SCO7721,
not likely to be involved in secondary metabolite biosynthesis.234 Chemistry & Biology 20, 232–240, February 21, 2013 ª2013 ElseAnalysis of the intergenic region between SCO7719 and
SCO7720 revealed repeated palindromic sequences (four
repeats, consensus TGCGTGCACGCA) characteristic of known
TFR binding sites (Figure 1C). We purified SCO7719 and exam-
ined its ability to bind the SCO7719-SCO7720 intergenic region
in the presence of kijanimicin using electrophoretic mobility shift
assays. Kijanimicin disrupted the SCO7719-DNA interaction
in vitro at a concentration of 25 mM, indicating that SCO7719
binds kijanimicin in vitro (Figure 2B). Based on the presence of
four repeated palindromic sequences, we predicted that in the
absence of kijanimicin, the DNA probe will be bound by four
SCO7719 dimers. The intermediate shifts observed between
unbound and fully shifted DNA when kijanimicin is added are
likely to represent DNA fragments bound at only one, two, or
three of the SCO7719 binding sites.
We next examined the expression of SCO7720 using a fusion
of its promoter to the luxCDABE genes. Expression from the
SCO7720 promoter was dependent on kijanimicin and was
induced at concentrations as low as 100 nM (Figure 2C). We
observed a delay in expression from the SCO7720 promoter at
high kijanimicin concentrations that we did not observe for
expression from the kijA5 promoter at the same concentrations
(Figure 2A). Furthermore, 1 mM kijanimicin was required forvier Ltd All rights reserved
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Figure 2. SCO7719 Binds Kijanimicin and Controls SCO7720 Expression
(A) Time course of kijA5 (from A. kijaniata) expression induced by kijanimicin using a lux reporter.
(B) Electrophoretic mobility shift assay between SCO7719 and the SCO7719-20 intergenic region in the presence and absence of kijanimicin.
(C) Time course of kijanimicin-induced SCO7720 expression using a lux reporter. lux expression was driven from the SCO7720 promoter with SCO7719 encoded
in cis and driven from its native promoter.
(D) Summary of induction of KijA8 homologs with kijanimicin and structurally related molecules. Amino acid identity and similarity relative to KijA8 are indicated.
CPS, counts per second; Kij, kijanimicin; Chl, chlorothricin; ScarA, saccharocarcin A; ScarB, saccharocarcin B; TmA, tetromycin A; TmB, tetromycin B.
Error bars indicate standard deviations from triplicate samples.
See also Tables S3 and S4.
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kijanimicin concentrations recognized by KijA8 and SCO7719
could reflect differences in the kijanimicin concentrations
experienced by producing strains and neighboring organisms.
Saccharocarcin A and B, which share structural similarities
with kijanimicin, were also found to induce expression from the
SCO7720 promoter, whereas three other related secondary
metabolites, chlorothricin and tetromycins A and B, did not
(Figure 2D). These data are consistent with a model in which
SCO7720 expression is repressed by SCO7719 with kijanimicin
and closely related molecules acting as inducing ligands for
SCO7719 and SCO7720 expression.
We also tested kijanimicin and related molecules for their
ability to act as ligands for other KijA8 homologs identified in
our relational tree. The ligand-binding profiles observed are
consistent with the topology of our relational tree (Figure 2D).
TFRs in the same cluster as SCO7719 bound the same ligands,
whereas more distant TFRs did not bind any of the ligands
tested.
SCO7720 Inactivates Kijanimicin through
Deglycosylation
Identifying the small molecule recognized by a TFR provides the
basis for investigating the function of the gene(s) regulated, as
the same or a closely related molecule is usually the ligand for
both the regulator and the target gene. Because SCO7720
expression was induced by kijanimicin, we investigated theChemistry & Biology 20, 232role of SCO7720 in kijanimicin resistance. We found that
expressing SCO7720 in the kijanimicin-sensitive host Strepto-
myces venezuelae resulted in a reproducible 4-fold increase in
the minimum inhibitory concentration of kijanimicin, suggesting
a role in resistance (Figure 3A). Indeed, SCO7720 expression
also conferred a 2-fold increase in resistance to the two other
SCO7719 ligands saccharocarcins A and B but did not alter
resistance to chlorothricin or tetromycins A and B (data not
shown). Thus, we observed a perfect correlation between the
resistance profile conferred by SCO7720 and the ligand-binding
profile of SCO7719. These data provide strong evidence for the
role of SCO7720 in kijanimicin resistance.
To test the ability of SCO7720 to inactivate kijanimicin, we
examined the antimicrobial activity of kijanimicin after incubation
with cells expressing SCO7720 using B. subtilis as an indicator
organism (Figure 3B). After 24 hr of incubation, no antimicrobial
activity was detected from kijanimicin incubated with cells
expressing SCO7720 but was unchanged in cells containing
empty vector, consistent with a role for SCO7720 in enzymatic
inactivation of kijanimicin. Treatment of kijanimicin with
SCO7720 also destroyed the ability of kijanimicin to induce
SCO7720 expression (Figure 3C), further supporting a role for
SCO7720 in kijanimicin inactivation.
Enzymatic inactivation of antibiotics is known to occur by
both degradation and group transfer (Morar and Wright, 2010).
To determine the mechanism of kijanimicin inactivation by
SCO7720, we examined samples inactivated by S. venezuelae–240, February 21, 2013 ª2013 Elsevier Ltd All rights reserved 235
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mass spectrometry (Figure 4). In the absence of SCO7720
treatment, a single major peak was observed corresponding
to kijanimicin. Treatment with SCO7720 resulted in the loss of
kijanimicin and the appearance of new molecular species with
m/z values of 783 [M+H]+ and 575 [M+Na]+. Tandem mass
spectrometry was used to further ascertain the identity of the
kijanimicin inactivation products. Fragmentation products for
the 783 species were consistent with kijanimicin minus the
four-sugar oligosaccharide, whereas those for the 575 species
were consistent with the four-sugar oligosaccharide (Figure S3).
Elemental composition based on high-resolution mass spec-
trometry for the two species support our structural assignments
with delta ppm values of 0.569 and 1.3 for the 575 and 783
species, respectively. These data are consistent with the
presence of a hydroxyl group on both products, indicating
that SCO7720 functions as a glycosyl hydrolase, rather than
a lyase, cleaving the oligosaccharide from kijanimicin. Similar
results were obtained for treatment of saccharocarcin A with
SCO7720 (see Figure S4). Because of their role in recognizing
and inactivating kijanimicin, we rename SCO7719 and
SCO7720 as kijR and kijX, respectively. This is an example of
inducible resistance to kijanimicin, and indeed it is an example
of antibiotic inactivation through deglycosylation.
DISCUSSION
The explosion of prokaryotic genome sequencing has led to an
overwhelming need for improved methods to predict protein
function. The use of phylogenomics can be a powerful tool to
aid these predictions (Eisen, 1998). Here, we report the applica-
tion of phylogenetic methodology for the specific and important
purpose of predicting small-molecule ligands for transcriptional
regulators. The result is a global relational tree that captures
much of the TFR sequence diversity and organizes it into a useful
set of subfamilies. By incorporating the known and predicted
TFR ligands into the tree, we have organized TFRs into functional
subgroups in a manner that can facilitate the identification of
ligands for TFRs and infer biological function for their target
gene(s).
Using this information we have identified the cognate ligand
for the S. coelicolor protein KijR (SCO7719). It is important
to emphasize that KijR and KijA8 are not simply orthologs as
the two proteins regulate unrelated target genes and are in
completely different genomic contexts. It is also worth noting
that, as is the casewithmany TFRs of unknown function, a simple
BLAST search of the protein database with KijR does not readily236 Chemistry & Biology 20, 232–240, February 21, 2013 ª2013 Elseidentify KijA8 as a relevantly similar homolog. The list of similar
protein sequences is so large that this relationship is buried.
By focusing on a representative set of genomes and by taking
advantage of the capacity of phylogenetic methodologies to
organize and cluster large groups of related protein sequences,
our relational tree creates a more manageable database.
The key insight we gained using the relational tree led directly
to the elucidation of the function and biochemical mechanism of
KijX (SCO7720). This discovery was only made possible by the
identification of the inducing ligand for KijR. There are no KijX
orthologs of known function in the sequence databases or
indeed in the kijanimicin biosynthetic gene cluster. The genomic
clustering of TFRs with their target genes is a common feature
of the family (Ahn et al., 2012), so it is likely that our approach
could be successfully applied to the characterization of many
other proteins of unknown function. Indeed, in our work on
chromosomal context we found that most of the target genes
for TFRs are likely to be enzymes of currently unknown function:
our approach is therefore likely to be useful for elucidating the
biochemical roles of these proteins.
The identification of KijX as an antibiotic deglycosylase is an
important discovery as there are numerous glycosylated natural
products, many with clinical importance (Kren and Rezanka,
2008). Sugar residues are known to be important for the function
of glycosylated natural products. The identification of a protein
with antibiotic deglycosylase activity can be applied to the
creation of novel semisynthetic derivatives with altered biolog-
ical properties.
Identification of a new antibiotic resistance mechanism in
a nonproducing species also underscores the preexisting reser-
voir of antibiotic resistance in natural environments (D’Costa
et al., 2006). A search for KijX homologs indicates that they
are not limited to streptomycetes but are also found in human
pathogens (Burkholderia, Nocardia, and Nocardiopsis), human
microbiome strains (Paenibacillus), archaea (Methanobacterium
andMethanosphaerula), and fungi (Neosartorya, Penicillium, and
Trichoderma). The KijX homologs in the database are annotated
as hypothetical proteins with no connection to kijanimicin or
other antibiotics: our elucidation of the protein’s biochemical
role as a glycosyl hydrolase will enable the understanding of
many KijX-related proteins.
The tree includes all the TFRs of the principle model prokary-
otes and many important pathogens: we believe therefore that it
will provide valuable orthogonal data to investigators studying
these bacteria. To apply the tree more broadly, for example,
to a TFR discovered in an organism not represented in the
tree, an investigator can simply search the proteins of the 211vier Ltd All rights reserved
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Figure 4. SCO7720 Deglycosylates Kijanimicin
Culture media of cells expressing SCO7720 grown in the presence of 100 mM
kijanimicin were analyzed by liquid chromatography with inline mass spec-
trometry. Inactivation of kijanimicin by SCO7720 resulted in the disappearance
of the kijanimicin peak (m/z 1,317 and 1,339) and the formation of two new
peaks (m/z 783 and 575).
See also Figures S3 and S4 and Tables S3 and S4.
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similar protein and find its corresponding group in our relational
tree. We have found that our tree included strong hits for most
of the TFRs in two recently reported genomes, none of which
had been used in the tree’s construction. We have identified
many other examples of groups containing both TFRs of
unknown function and TFRs encoded within antibiotic biosyn-
thesis clusters. For example, LanK, which binds landomycin
A (Ostash et al., 2008), grouped with SaqK and UrdK, which
are encoded in the biosynthetic gene clusters for structurally
related antibiotics, as well as ten TFRs of unknown function.
BecM, MlaM, and Strop_2766, all encoded within the biosyn-Chemistry & Biology 20, 232thetic clusters for macrolactam antibiotics, grouped with 16
TFRs of unknown function, two of which are also located in
antibiotic biosynthesis clusters. NapR3 and NapR7 from the na-
pyradiomycin biosynthesis cluster grouped with seven TFRs of
unknown function. PlaR2 from the phenalinolactone biosyn-
thesis cluster groups with six TFRs of unknown function. These
examples highlight the utility of our analysis in identifying TFRs
regulating antibiotic resistance. We also identified subfamilies
that are predicted to interact with many other classes of mole-
cules, including a conspicuous number of acyl-CoA derivatives
and intermediates. Consistent with this, a small but representa-
tive set of TFRs have been shown to interact with suchmolecules
previously (Eaton, 1997; Matsuoka et al., 2007; Li et al., 2011;
Sakamoto et al., 2011).
Finally, given the vast wealth of genome sequence information
now available, most ligand binding protein families are repre-
sented by hundreds or thousands of mostly uncharacterized
members. We suggest that approaches similar to the one we
have described here will be crucial to our understanding of
how bacteria sense and respond to their surroundings.SIGNIFICANCE
Identifying the cognate ligands for small-molecule binding
receptors represents a major challenge in microbial chemi-
cal biology. Small-molecule receptors, such as transcription
factors, can be easily identified in genome sequences based
on conservation of their DNA-binding domains. However,
identifying the precise molecular nature of their cognate
small-molecule ligands is much more difficult. We have
used phylogenomics to create a relational neighbor-joining
tree to predict ligands for members of the TetR-family of
regulators (TFRs). Our approach can also be applied to the
identification of ligands for other families of both prokary-
otic and eukaryotic transcription factors.
Using our tree, we identify the antibiotic kijanimicin as
the inducing ligand for a TFR of previously unknown func-
tion, SCO7719, which we name KijR, from Streptomyces
coelicolor. We show that KijR regulates SCO7720, which
we name kijX, in response to kijanimicin. Kijanimicin
belongs to a family of antibiotics containing a spirotetronate
moiety that shows a diverse array of biological effects. We
further demonstrate that kijX encodes a kijanimicin-resis-
tance determinant and inactivates kijanimicin through
deglycosylation. This, is a demonstration of antibiotic
resistance through deglycosylation. Given the abundance
of glycosylated natural products and the importance of
glycosylation for the activity of thesemolecules, inactivation
via deglycosylation is likely to be widespread. Identification
of KijX as an antibiotic deglycosylase will aid in identifica-
tion of other small-molecule glycosyl hydrolases and can
be applied to the creation of novel semisynthetic derivatives
with altered biological properties.EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Growth Conditions
Strains and plasmids used in this study are described in Table S3. Actinomy-
cetes were routinely grown in 2x YT (Kieser et al., 2000) at 30C with shaking–240, February 21, 2013 ª2013 Elsevier Ltd All rights reserved 237
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Inducible Antibiotic Resistanceat 200 rpm. E. coli was grown in liquid Luria-Bertani (LB) or on LB supple-
mented with agar (Maniatis, 1989). Media was supplemented with apramycin
(50 mg/ml) or kanamycin (50 mg/ml) where required.
DNA methods
The oligonucleotides used in this study were obtained from Sigma-Genosys
(Oakville, ON) and are described in Table S4. Standard procedures were
used for DNA isolation, cloning, and analysis (Maniatis, 1989). The insert
used in the construction of plux-KijA5 was chemically synthesized (Genscript,
Piscataway, NJ). PCR amplification was carried out under conditions optimal
for each primer pair using Vent DNA polymerase (New England Biolabs,
Ipswich, MA). DNA sequencing was performed at MOBIX (McMaster Univer-
sity). Strain construction in S. coelicolor was conducted using established
protocols (Kieser et al., 2000).
Phylogenetic Methods
The genomes of 211 strains of bacteria and archaea with representatives
from all 30 bacterial phyla were searched using the BLAST algorithm and
the pfam00440 consensus sequence for the DNA-binding domain of TFR.
Searches were conducted on genomes available as of January 2012 with
a preference for completed genome sequences where available. Where
possible, the genome locus tags were used as sequence identifiers; however,
in some cases, they had to be abbreviated to ten characters to ensure com-
patibility with phylogenetic programs (see Table S1). Sequences were aligned
using CLUSTALW (Thompson et al., 1994), and the final sequence alignment
was examined to ensure alignment of conserved secondary structure
elements present in TFRs (Yu et al., 2010). A neighbor-joining tree was con-
structed using the PHYLIP package and 100 bootstrap trials (Felsenstein,
1989). Trees were viewed using SplitsTree (Huson and Bryant, 2006) and
Dendroscope (Huson et al., 2007).
Protein Purification and Electrophoretic Mobility Shift Assays
E. coli BL21(DE3) cells harboring pET28-SCO7719 were grown at 37C, to an
OD600 of 0.4, and SCO7719 expression was induced through the addition of
1 mM IPTG to the growth medium. Cells were allowed to grow for an additional
3 hr and then collected by centrifugation at 4,000 rpm for 15 min at 4C in an
SLA-3000 rotor. Cells were lysed using the BugBuster reagent (Novagen,
Madison, WI) in accordance with the manufacturer’s instructions. An equal
volume of buffer A (50 mM Tris [pH 7.9], 0.5 M NaCl, and 20 mM imidazole)
was added, and the lysate was cleared by centrifugation at 12,000 rpm for
30 min at 4C in an SS34 rotor. The cleared lysate was filtered through
a 0.45 mm filter to remove smaller debris and insoluble protein. To this, 4 ml
of QIAGEN Ni-NTA agarose solution (Hilden, Germany) was added, and the
slurry was allowed to incubate for 1 hr at 4C with gentle shaking. The column
was washed with buffer A and eluted in buffer B (50 mM Tris [pH 7.9], 0.5 M
NaCl, and 1 M imidazole). Elution fractions were monitored by SDS-PAGE.
Fractions containing SCO7719 were pooled and exchanged into buffer C
(20 mM Tris [pH 7.9], 0.5 M NaCl, and 20% v/v glycerol). The desalted protein
was concentrated using an Amicon Ultra Centrifugal Filter (10,000 MWCO;
Millipore, Billerica, MA).
Electrophoretic mobility shift assays were carried out as previously
described (Tahlan et al., 2007) using 64 nM purified SCO7719. Primers
7719pF and 7719pR were used to amplify the SCO7719-SCO7720 intergenic
region. DNA probes were end labeled using [g32P]-ATP (Maniatis, 1989). All
molecules were dissolved in DMSO.
lux Reporter Assays
Strains containing the lux reporter plasmids in S. coelicolor were inoculated
at a concentration of 5 3 106 cfu/ml in 2x YT and allowed to grow for 16 hr.
Time course assays were carried out in 96-well plates using 99 ml of the
16 hr culture and 1 ml of molecule at different stock concentrations dissolved
in DMSO. Chlorothricin, kijanimicin, saccharocarcins A and B and tetromycins
A and Bwere obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Purity
from the supplier is reported as follows: chlorothricin, >99%, kijanimicin,
>99%; saccharocarcin A, >95%; saccharocarcin B, >99%; tetromycin A,
>99%; tetromycin B, >99%. Glass beads (3 mm) were added to each well to
increase aeration. Plates were incubated at 30C with shaking, and lumines-238 Chemistry & Biology 20, 232–240, February 21, 2013 ª2013 Elsecence was read using a VictorX Light luminescence plate reader (Perkin Elmer,
Waltham, MA). All lux assays were done in triplicate.
Kijanimicin Inactivation and Analysis
Kijanimicin and saccharocarcin A inactivation was carried out in a manner
similar to established methods but using whole cells instead of culture super-
natant (D’Costa et al., 2006). S. venezuelae cells containing either pSET152 or
pSET-SCO7720 grown for 16 hr in 2x YT were used as the source of enzyme.
Cell growth was monitored by optical density to ensure an equal number of
cells were used in each reaction. Kijanimicin or saccharocarcin A were added
to a final concentration of 100 mM, and reactions were incubated with shaking
at 30C for 24 hr. Cells were removed by centrifugation, and the antibiotic
activity in culture supernatants was monitored by disk diffusion assay using
10 ml of each sample and B. subtilis 168 as the test organism.
Inactivated samples were extracted twice with an equal volume of ethyl
acetate, dried using a centrifugal evaporator (Genevac HT-4x), and resus-
pended in acetonitrile. Samples were analyzed by liquid chromatography-
tandemmass spectrometry (LC-MS/MS) (Agilent 1200 ‘‘RR’’ series LC system
and a Bruker micrOTOF II time-of-flight MS with an ESI ionization source)
using a C18 column (Phenomenex Kinetex, 50 3 2.1 mm, 2.6 mm, 100 A˚).
Formic acid (0.1%) in water (solvent A) and 0.1% formic acid in acetonitrile
(solvent B) were used as solvents. A flow rate of 0.2 ml/min was used with
a gradient of 5% B to 95% B over 5 min and a final 4 min elution in 95% B.
For MS, the capillary voltage was set to 4.5 kV with nebulizing gas pressure
(N2) of 3 barr, dry gas flow rate (N2) of 6 l/min, temperature at 200
C, and
a scan rate of 1 Hz.
To further examine the structures of the kijanimicin and saccharocarcin
A inactivation products, we performed tandem mass spectrometry. Formic
acid was added to a final concentration of 0.1% and analyzed by microflow
liquid chromatography electrospray tandem mass spectrometry (micro-LC-
ESI-MS/MS) using a ThermoFisher LTQ-XL-Orbitrap Hybrid Mass Spectrom-
eter (ThermoFisher, Waltham, MA) coupled to an Eksigent nano LC-2D HPLC
system (Eksigent, Dublin, CA). Chromatography was performed using 0.1%
formic acid in both solvent C (98% water, 2% acetonitrile) and solvent D
(80% acetonitrile, 10% isopropanol, and 10% water) and a 5% D to 95% D
gradient over 30 min using a 5 ml/min flow rate through an Eksigent capillary
(CSP-3 C18 100, 0.3 m 3 100 mm) column. The instrument method con-
sisted of one MS full scan (200–2,000 m/z) in the Orbitrap mass analyzer, an
automatic gain control target of 500,000 with a maximum ion injection of
500 ms, one microscan, and a resolution of 60,000. Three data-dependent
MS/MS scans were performed in the linear ion trap using the three most
intense ions at 35% normalized collision energy. The MS and MS/MS scans
were obtained in parallel fashion. In MS/MS mode, automatic gain control
targets were 10,000 with a maximum ion injection time of 100 ms. A minimum
ion intensity of 1,000 was required to trigger an MS/MS spectrum. The
dynamic exclusion was applied using a maximum exclusion list of 500 with
one repeat count with a repeat duration of 30 s and exclusion duration of
45 s. Positive ESI source conditions were sheath gas flow rate at 10, auxiliary
gas flow rate at 5, ion spray voltage at 3.9 kV, capillary temperature at 200C,
capillary voltage at 40 V, and tube lens voltage at 150 V. The lock-mass
option was enabled for the FT full scans using the ambient air polydimethyl-
cyclosiloxane (PCM) ion of m/z = 445.120024 or a common phthalate ion
m/z = 391.284286 for real time internal calibration. All MS/MS samples were
analyzed using FT Programs Software: Mass Frontier 7.0 (ThermoFisher).
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